BeyondSpring Inc. is projected to rise to $1.20 by 2027, a +2% move from its current price of $1.17. BYSI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.13 | $1.17 | $1.21 | -0.06% |
| Aug 6 | $1.11 | $1.17 | $1.23 | -0.11% |
| Aug 7 | $1.10 | $1.17 | $1.24 | -0.17% |
| Aug 8 | $1.09 | $1.17 | $1.25 | -0.22% |
| Aug 9 | $1.08 | $1.17 | $1.26 | -0.28% |
| Aug 10 | $1.07 | $1.17 | $1.27 | -0.34% |
| Aug 11 | $1.06 | $1.17 | $1.28 | -0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.06 | $1.17 | $1.28 | -0.39% |
| Week 2 | $1.01 | $1.16 | $1.33 | -0.78% |
| Week 3 | $0.9798 | $1.16 | $1.36 | -1.17% |
| Week 4 | $0.9512 | $1.15 | $1.39 | -1.55% |
| Week 5 | $0.9264 | $1.15 | $1.42 | -1.94% |
| Week 6 | $0.9041 | $1.14 | $1.44 | -2.32% |
| Week 7 | $0.8838 | $1.14 | $1.47 | -2.71% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform.
The lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for non-small cell lung cancer and for the prevention of chemotherapy-induced neutropenia. BeyondSpring also explores combinations with immuno-oncology agents and other therapies, including antibodies and chemotherapy regimens, to treat NSCLC and other cancers.
The company was founded in 2010 and is headquartered in Florham Park, New Jersey. It trades in the Healthcare sector and pursues a portfolio of clinical-stage programs to advance cancer and immune-related indications.
BeyondSpring Inc. (BYSI) is a healthcare company whose stock currently trades at $1.13 per share and carries a market cap of $46.47M. The stock is ranked 4406 by market capitalization among listed assets. The current price sits in a context of a broader forecast that projects sequential years of evolving价格 path and returns.
The forecast table shows a progression in average prices from a flat start in 2026 through 2029, followed by meaningful upside into the 2030s and beyond. The line between neutral and bullish outlook widens in later years, with 2031 onward consistently labeled as BULLISH and large potential upside implied by the max forecast values.
A major floor 50.7% below — a decisive break under it would weaken the trend.
The nearest floor, 7.7% below — buyers have tended to step in here.
The nearest ceiling, 59.8% above — a clean break opens room to run.
A major ceiling 84.3% above — clearing it would confirm fresh momentum.
Key BYSI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BYSI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.16 | Buy | $1.15 | Buy |
| MA 10 | $1.16 | Buy | $1.19 | Sell |
| MA 20 | $1.31 | Sell | $1.29 | Sell |
| MA 50 | $1.52 | Sell | $1.44 | Sell |
| MA 100 | $1.56 | Sell | $1.52 | Sell |
| MA 200 | $1.66 | Sell | $1.62 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.04 | Neutral |
| Stoch RSI (14) | 94.14 | Sell |
| CCI (20) | -67.60 | Neutral |
| Williams %R (14) | -72.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -9.45 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 28.00 | Neutral |
| TRIX (15) | -1.15 | Sell |
| Awesome (5,34) | -0.30 | Sell |
| Ultimate (7,14,28) | 45.00 | Neutral |
| Momentum (10) | -0.14 | Sell |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 1.15 | Buy |
| ADX (14) | 29.61 | Sell |
| ATR (14) | 0.05 | Info |
Technical sentiment is NEUTRAL with an RSI of 30. The stock trades below the 50-day and 200-day simple moving averages, indicated by SMA50 at $1.56 and SMA200 at $1.68. Near-term support sits at $1.13, with resistance at $1.87. Over the last 30 days, the price range has fluctuated between $0.8639 and $1.48, illustrating a cautious trading band.
These near-term metrics suggest limited upside momentum in the immediate horizon, with the price trading near or below the short- and long-term moving averages and a cautious RSI reading.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.08 | $1.17 | $1.44 | 0% | Neutral | |
| $0.926 | $1.20 | $1.65 | +2% | Neutral | |
| $0.8549 | $1.15 | $1.66 | -2% | Neutral | |
| $0.851 | $1.18 | $1.77 | +1% | Neutral | |
| $0.9854 | $1.41 | $2.18 | +20% | Bullish | |
| $1.09 | $1.59 | $2.53 | +36% | Bullish | |
| $1.22 | $1.84 | $2.99 | +57% | Bullish | |
| $1.17 | $1.80 | $3.00 | +54% | Bullish | |
| $1.03 | $1.62 | $2.75 | +39% | Bullish | |
| $1.15 | $1.85 | $3.19 | +58% | Bullish | |
| $1.52 | $2.69 | $5.01 | +130% | Bullish | |
| $1.87 | $3.96 | $8.19 | +238% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.08 | $1.17 | $1.44 | +0.00% |
| September 2026 | $0.988 | $1.18 | $1.45 | +0.78% |
| October 2026 | $0.9231 | $1.11 | $1.39 | -5.71% |
| November 2026 | $0.8989 | $1.09 | $1.38 | -1.88% |
| December 2026 | $0.9239 | $1.13 | $1.44 | +3.49% |
Click any year to see its month-by-month BYSI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect BYSI to range from $1.08 to $1.44 through 2026. The $1.17 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The BYSI price prediction for 2027 points to an average of $1.20 (low $0.926, high $1.65) — a potential gain of +2% on today's $1.17. A consolidation phase looks the most probable path here.
In 2028, BYSI is projected to trade between $0.8549 and $1.66, averaging $1.15 — a potential decline of -2% from today's $1.17. That is -4% versus the projected 2027 average. Price action looks broadly range-bound.
BeyondSpring Inc.'s 2029 outlook centres on $1.18, within a $0.851 to $1.77 range. That is up +3% on the projected 2028 average. That marks a +1% change versus current levels. A consolidation phase looks the most probable path here.
By 2030, BYSI could reach as high as $2.18, with a base case around $1.41 and support toward $0.9854 — roughly +20% from $1.17. Momentum favours further upside here.
Expect BYSI to range from $1.09 to $2.53 through 2031. The $1.59 average target implies a +36% move from current prices. That is up +13% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The BYSI price prediction for 2032 points to an average of $1.84 (low $1.22, high $2.99) — a potential gain of +57% on today's $1.17. Momentum favours further upside here.
In 2033, BYSI is projected to trade between $1.17 and $3.00, averaging $1.80 — a potential gain of +54% from today's $1.17. That is -2% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
BeyondSpring Inc.'s 2034 outlook centres on $1.62, within a $1.03 to $2.75 range. That is -10% versus the projected 2033 average. That marks a +39% change versus current levels. Momentum favours further upside here.
By 2035, BYSI could reach as high as $3.19, with a base case around $1.85 and support toward $1.15 — roughly +58% from $1.17. Buyers look set to stay in control over this stretch.
Expect BYSI to range from $1.52 to $5.01 through 2040. The $2.69 average target implies a +130% move from current prices. That is up +46% on the projected 2035 average. Momentum favours further upside here.
The BYSI price prediction for 2050 points to an average of $3.96 (low $1.87, high $8.19) — a potential gain of +238% on today's $1.17. Buyers look set to stay in control over this stretch.
Investing $1,000 in BYSI today (≈ 854.700855 BYSI) could be worth
$3,382.37
+$2,382.37 (+238%) by 2050 · US Dollar
Based on the average projected BYSI price of $3.96 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BYSIwould be worth at today's price.
$1,000 invested in BYSI on Jul 31, 2025 (≈ 487.804889 BYSI) would be worth
$570.73
-$429.27 (-42.9%) today · 0.57× · US Dollar
Based on a BYSI entry price of $2.05 vs. today's $1.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.12 | $1,044.64 | +4.5% |
| 1 month ago | $1.85 | $632.43 | -36.8% |
| 3 months ago | $1.49 | $785.23 | -21.5% |
| 6 months ago | $1.56 | $750 | -25.0% |
| 1 year ago | $2.05 | $570.73 | -42.9% |
| All time (5.0y) ago | $21.7 | $53.92 | -94.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BYSI forecast.
Our base-case forecast reaches $2.30 around 2040.
Implied market cap at $2.30: $94.58M
The multi-year forecast shows a gradual transition from neutral to bullish sentiment as the horizon extends. In 2026 the min and avg prices are both $1.13 with a max of $1.41 and an ROI of 0%. By 2030 the avg rises to $1.30 with a max of $2.07 and an ROI of 14.8%, reflecting a notable improvement in the price path.
The years 2031 through 2035 display stronger bullish signals, with 2031 avg $1.54 (ROI 36.1%), 2032 avg $1.74 (ROI 53.9%), 2033 avg $1.66 (ROI 47.2%), 2034 avg $1.52 (ROI 34.4%), and 2035 avg $1.72 (ROI 51.9%).
Beyond 2040, the forecast shows continued upside, with 2040 avg $2.52 (ROI 123.2%) and 2050 avg $3.56 (ROI 214.6%). The 2040 and 2050 max values reach $4.91 and $7.77 respectively, underscoring the potential for substantial appreciation if the forecast materializes. These are estimates and not guarantees, and actual results can differ due to market and company-specific factors.
Tap a question to reveal the answer.
In 2030, the forecasted average price is $1.30 with a max of $2.07 and a min of $0.8802, yielding an ROI of 14.8% and a NEUTRAL sentiment.
Forecasts show NEUTRAL sentiment through 2029, with rising bullish momentum from 2031 onward. The sequence of average prices climbs from $1.54 in 2031 to $3.56 by 2050, with ROIs of 36.1% in 2031, 53.9% in 2032, 47.2% in 2033, 34.4% in 2034, 51.9% in 2035, 123.2% in 2040, and 214.6% in 2050.
Yes. The forecast shows a max of $3.09 in 2035, $4.91 in 2040, and $7.77 in 2050.
Current price is $1.13 and market capitalization is $46.47M.
RSI(14) is 30. The SMA50 is $1.56 and SMA200 is $1.68. Support is at $1.13 and resistance at $1.87. The 30-day price range runs from $0.8639 to $1.48.
BeyondSpring Inc. Community Discussion
0Share your BeyondSpring Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.